RYAN SHEPHARD: Open Payments
NPI 1326722703 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,755 in 146 payments from 26 companies in 2025. Trend: 2023 $790 · 2024 $3,044 · 2025 $2,755
Food & beverage: $2,755
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $464 |
| Amgen Inc. | 21 | $323 |
| ABBVIE INC. | 16 | $277 |
| Madrigal Pharmaceuticals | 8 | $196 |
| Lilly USA, LLC | 15 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $177 |
| Novo Nordisk Inc | 12 | $155 |
| Astellas Pharma US Inc | 6 | $123 |
| PFIZER INC. | 6 | $112 |
| Otsuka America Pharmaceutical, Inc. | 4 | $107 |
Products named: BREZTRI, VRAYLAR, REZDIFFRA, Kerendia, REPATHA, MOUNJARO, Veozah, Wegovy.
Industry payments across CO — which companies pay providers there.
